Earlier quoted context omitted.
labs in India and China.
India has been pretty open and vocal about ignoring pharma patents when it comes to medications. They put the needs of the people above the financial wants of the industry. It's been a cause of tension in trade negotiations.
US doesn't put as much pressure because India used "Bhopal Gas Plant Tradegy" for negotiation.
If US really wanted to enforce anything, they could have simply banned outsourcing to India.
There is lots of damage US can do to India on that front, they don't care enough for now for it to matter.